DAVIDSON MICHAEL H. (Chief Executive Officer) purchased 1.3% of their position (10K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Open‑market purchase worth $226.5K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/15/2026ACC: 0001193125-26-391985
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+10K
Net shares
Net buyer
$226.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+10K
Price / share
$22.65
Trade value
$226.50K
% of position
1.3%
9/14/2026
782.92K→792.92K
Total
Net shares
+10K
Net value
$226.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/14/2026 | P · Purchase | +10K | $22.65 | $226.50K | 1.3% | 782.92K | 792.92K |
| Total | +10K | $226.50K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned285.71K
Total
285.71K indirect285.71K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 285.71K | Indirect |
| Total | 285.71K | 285.71K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported